Europe Uterine Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Europe Uterine Cancer Diagnostics Market, By Diagnostic Type (Instrument Based and Procedure Based), Type (Endometrial Cancer And Uterine Sarcoma), Age Group (<30, 31-40, 41-50, 51-60 And >60), End User (Hospitals, Diagnostic Centres, Cancer Research Centre, Ambulatory Surgical Centres, Specialized Clinics, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe) Industry Trends and Forecast to 2030
Market Definition
Diagnosis of uterine cancer includes ultrasound, biopsy procedures, and blood tests. Ultrasound tests use sound waves and produce images of the ovaries and uterus. Two types of ultrasound are included in diagnostic testing for uterine cancer: abdominal ultrasound and transvaginal ultrasound. An abdominal scan test involves scanning the full bladder with a small probe across the abdomen, while a transvaginal scan involves inserting a probe tube into the vagina to scan or create an image. Biopsy procedures include endometrial biopsy, hysteroscopy, and dilation and curettage.
Cancer is one of the leading causes of death worldwide, and the prevalence of this disease has increased at an alarming rate. Therefore, health professionals are focusing on developing effective screening and treatment solutions to control obesity rates. Moreover, an endometrial biopsy involves removing some malignant tissue from the endometrium and sending it for a testing procedure. The growing number of geriatric women in the U.S. is also a major factor contributing to the growth of the uterine cancer diagnostic market.
Market Segmentation
The Europe uterine cancer diagnostic market is segmented into five notable segments which are based on diagnostic type, type, age group, end user, and distribution channel.
• On the basis of diagnostic type, the Europe uterine cancer diagnostic market is segmented into instrument based and procedure based
• On the basis of type, the Europe uterine cancer diagnostic market is segmented into endometrial cancer and uterine sarcoma
• On the basis of age group, the Europe uterine cancer diagnostic market is segmented into <30, 31-40, 41-50, 51-60, and >60
• On the basis of end user, the Europe uterine cancer diagnostic market is segmented into hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, specialized clinics, and others
• On the basis of distribution channel, the Europe uterine cancer diagnostic market is segmented into direct tender, third party distributors, and others
Market Players
Some of the major players operating in the Europe uterine cancer diagnostic market are:
• F-Hoffmann La Roche Ltd.
• Siemens Healthcare Private Limited
• ESAOTE SPA
• Olympus Corporation
• Integra LifeSciences
• KARL STORZ SE & Co. KG
• Stryker
• General Electric Company
• FUJIFILM Corporation
• Koninklijke Philips N.V.
• B. Braun SE
• Arquer Diagnostics Ltd
• Surtex Instruments Limited
• GRAIL
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Europe Uterine Cancer Diagnostic Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Dbmr Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Market Application Coverage Grid
- 2.8 Instrument Based Lifeline Curve
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces
- 4.3 Patent Analysis Of Europe Uterine Cancer Diagnostics Market
- 4.4 Reimbursement Scenario
- 4.5 Industry Insights:
- 4.6 Demographic Trends: Impacts On All Incidence Rates
- 4.7 Pricing Strategies
- 4.8 Conclusion
- 4.9 Prevalence, Incidence, And Mortality Rate Of Uterine Cancer
- 4.10 Cost Of Uterine Cancer Procedure
- 5 Regulatory Framework
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Technological Advancements In Uterine Cancer Diagnostics
- 6.1.2 Rising Demand For Minimally Invasive Advanced Screening Techniques
- 6.1.3 Rising Awareness Towards Uterine Cancer
- 6.1.4 Rising Importance Of Women's Health
- 6.2 Restraints
- 6.2.1 High Risk Complications During Diagnostic Tests
- 6.2.2 Lack Of Skilled Professionals For Proper Diagnosis Of Uterine Cancer
- 6.3 Opportunities
- 6.3.1 Increasing Prevalence Of Uterine Cancer
- 6.3.2 Rise In Adoption Of Sedentary Lifestyle
- 6.3.3 Growth In Menstrual Complications
- 6.4 Challenges
- 6.4.1 Lack Of Diagnostic Infrastructure
- 6.4.2 High Cost Of Imaging Systems
- 7 Europe Uterine Cancer Diagnostics Market, By Diagnostic Type
- 7.1 Overview
- 7.2 Instrument-based
- 7.2.1 Ultrasound Scanning
- 7.2.1.1 Systems
- 7.2.1.2 Abdominal Ultrasound Scanning
- 7.2.1.3 Transvaginal Ultrasound Scanning
- 7.2.1.4 Accessories
- 7.2.2 Imaging Devices
- 7.2.2.1 Ct/Pet (Positron Emission Tomography) Scan
- 7.2.2.2 Magnetic Resonance Imaging (Mri)
- 7.2.2.3 Computed Tomography (Ct) Scan
- 7.2.2.4 Others
- 7.2.3 Tests
- 7.2.3.1 Blood Tests
- 7.2.3.1.1 Complete Blood Count
- 7.2.3.1.2 Ca125 Marker Blood Test
- 7.2.3.2 Urine Tests
- 7.2.3.3 Other Tests
- 7.2.4 Others
- 7.3 Procedure Based
- 7.3.1 Endometrial Biopsy
- 7.3.2 Hysteroscopy
- 7.3.3 Dilation & Curettage
- 7.3.4 Cystoscopy
- 7.3.5 Proctoscopy
- 7.3.6 Others
- 8 Europe Uterine Cancer Diagnostics Market, By Type
- 8.1 Overview
- 8.2 Endometrial Cancer
- 8.2.1 Serous Adenocarcinoma
- 8.2.1.1 Instrument-based
- 8.2.1.1.1 Ultrasound Scanning
- 8.2.1.1.2 Imaging Devices
- 8.2.1.1.3 Tests
- 8.2.1.1.4 Others
- 8.2.1.2 Procedure-based
- 8.2.1.2.1 Endometrial Biopsy
- 8.2.1.2.2 Hysteroscopy
- 8.2.1.2.3 Dilation & Curettage
- 8.2.1.2.4 Cystoscopy
- 8.2.1.2.5 Proctoscopy
- 8.2.1.2.6 Others
- 8.2.2 Adenosquamous Carcinoma
- 8.2.2.1 Instrument-based
- 8.2.2.1.1 Ultrasound Scanning
- 8.2.2.1.2 Imaging Devices
- 8.2.2.1.3 Tests
- 8.2.2.1.4 Others
- 8.2.2.2 Procedure-based
- 8.2.2.2.1 Endometrial Biopsy
- 8.2.2.2.2 Hysteroscopy
- 8.2.2.2.3 Dilation & Curettage
- 8.2.2.2.4 Cystoscopy
- 8.2.2.2.5 Proctoscopy
- 8.2.2.2.6 Others
- 8.2.3 Uterine Carcinosarcoma
- 8.2.3.1 Instrument-based
- 8.2.3.1.1 Ultrasound Scanning
- 8.2.3.1.2 Imaging Devices
- 8.2.3.1.3 Tests
- 8.2.3.1.4 Others
- 8.2.3.2 Procedure-based
- 8.2.3.2.1 Endometrial Biopsy
- 8.2.3.2.2 Hysteroscopy
- 8.2.3.2.3 Dilation & Curettage
- 8.2.3.2.4 Cystoscopy
- 8.2.3.2.5 Proctoscopy
- 8.2.3.2.6 Others
- 8.2.4 Primary Pure Squamous Cell Carcinoma Of The Endometrium
- 8.2.4.1 Instrument-based
- 8.2.4.1.1 Ultrasound Scanning
- 8.2.4.1.2 Imaging Devices
- 8.2.4.1.3 Tests
- 8.2.4.1.4 Others
- 8.2.4.2 Procedure-based
- 8.2.4.2.1 Endometrial Biopsy
- 8.2.4.2.2 Hysteroscopy
- 8.2.4.2.3 Dilation & Curettage
- 8.2.4.2.4 Cystoscopy
- 8.2.4.2.5 Proctoscopy
- 8.2.4.2.6 Others
- 8.3 Uterine Sarcoma
- 8.3.1 Leiomyosarcoma
- 8.3.1.1 Instrument-based
- 8.3.1.1.1 Ultrasound Scanning
- 8.3.1.1.2 Imaging Devices
- 8.3.1.1.3 Tests
- 8.3.1.1.4 Others
- 8.3.1.2 Procedure-based
- 8.3.1.2.1 Endometrial Biopsy
- 8.3.1.2.2 Hysteroscopy
- 8.3.1.2.3 Dilation & Curettage
- 8.3.1.2.4 Cystoscopy
- 8.3.1.2.5 Proctoscopy
- 8.3.1.2.6 Others
- 8.3.2 Endometrial Stromal Sarcoma
- 8.3.2.1 Instrument-based
- 8.3.2.1.1 Ultrasound Scanning
- 8.3.2.1.2 Imaging Devices
- 8.3.2.1.3 Tests
- 8.3.2.1.4 Others
- 8.3.2.2 Procedure-based
- 8.3.2.2.1 Endometrial Biopsy
- 8.3.2.2.2 Hysteroscopy
- 8.3.2.2.3 Dilation & Curettage
- 8.3.2.2.4 Cystoscopy
- 8.3.2.2.5 Proctoscopy
- 8.3.2.2.6 Others
- 8.3.3 Undifferentiated Sarcoma
- 8.3.3.1 Instrument-based
- 8.3.3.1.1 Ultrasound Scanning
- 8.3.3.1.2 Imaging Devices
- 8.3.3.1.3 Tests
- 8.3.3.1.4 Others
- 8.3.3.2 Procedure-based
- 8.3.3.2.1 Endometrial Biopsy
- 8.3.3.2.2 Hysteroscopy
- 8.3.3.2.3 Dilation & Curettage
- 8.3.3.2.4 Cystoscopy
- 8.3.3.2.5 Proctoscopy
- 8.3.3.2.6 Others
- 9 Europe Uterine Cancer Diagnostics Market, By Age Group
- 9.1 Overview
- 9.2 >60 Years
- 9.3 51-60 Years
- 9.4 41-50 Years
- 9.5 31-40 Years
- 9.6 <30 Years
- 10 Europe Uterine Cancer Diagnostics Market, By End User
- 10.1 Overview
- 10.2 Hospitals
- 10.3 Diagnostic Centers
- 10.4 Cancer Research Centers
- 10.5 Ambulatory Surgical Centers
- 10.6 Specialized Clinics
- 10.7 Others
- 11 Europe Uterine Cancer Diagnostics Market, By Distribution Channel
- 11.1 Overview
- 11.2 Direct Tender
- 11.3 Third Party Distributors
- 11.4 Others
- 12 Europe Uterine Cancer Diagnostics Market, By Region
- 12.1 Europe
- 12.1.1 Germany
- 12.1.2 France
- 12.1.3 United Kingdom
- 12.1.4 Italy
- 12.1.5 Spain
- 12.1.6 Russia
- 12.1.7 Netherlands
- 12.1.8 Poland
- 12.1.9 Switzerland
- 12.1.10 Belgium
- 12.1.11 Sweden
- 12.1.12 Norway
- 12.1.13 Denmark
- 12.1.14 Finland
- 12.1.15 Turkey
- 12.1.16 Rest Of Europe
- 13 Europe Uterine Cancer Diagnostics Market, Company Landscape
- 13.1 Company Share Analysis: Europe
- 14 Swot Analysis
- 15 Company Profile
- 15.1 Koninklijke Philips N.V.
- 15.1.1 Company Snapshot
- 15.1.2 Revenue Analysis
- 15.1.3 Company Share Analysis
- 15.1.4 Product Portfolio
- 15.1.5 Recent Developments
- 15.2 Canon Medical Systems Anz Pty Limited.
- 15.2.1 Company Snapshot
- 15.2.2 Company Share Analysis
- 15.2.3 Product Portfolio
- 15.2.4 Recent Developments
- 15.3 General Electric Company
- 15.3.1 Company Snapshot
- 15.3.2 Revenue Analysis
- 15.3.3 Company Share Analysis
- 15.3.4 Product Portfolio
- 15.3.5 Recent Developments
- 15.4 Siemens Healthcare Gmbh
- 15.4.1 Company Snapshot
- 15.4.2 Revenue Analysis
- 15.4.3 Company Share Analysis
- 15.4.4 Product Portfolio
- 15.4.5 Recent Developments
- 15.5 Fujifilm Corporation
- 15.5.1 Company Snapshot
- 15.5.2 Revenue Analysis
- 15.5.3 Company Share Analysis
- 15.5.4 Product Portfolio
- 15.5.5 Recent Developments
- 15.6 Aed.Md
- 15.6.1 Company Snapshot
- 15.6.2 Product Portfolio
- 15.6.3 Recent Developments
- 15.7 Arquer Diagnostics Ltd
- 15.7.1 Company Snapshot
- 15.7.2 Product Portfolio
- 15.7.3 Recent Developments 451
- List Of Tables
- Table 1 Europe Rate Of Endometrial Cancer (2020)
- Table 2 U.S. (2022)
- Table 3 U.K. (2019)
- Table 4 Germany Rate Of Endometrial Cancer (2019)
- Table 5 Poland Rate Of Endometrial Cancer (2020)
- Table 6 Singapore (2020)
- Table 7 Japan (2022)
- Table 8 India (2020)
- Table 9 Australia (2022)
- Table 10 Brazil Rate Of Endometrial Cancer (2018)
- Table 11 Argentina (2020)
- Table 12 Uae (2020)
- Table 13 Europe Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 14 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 15 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 16 Europe Ultrasound Scanning In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 17 Europe Ultrasound Scanning In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Units)
- Table 18 Europe Systems In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 19 Europe Systems In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Units)
- Table 20 Europe Imaging Devices In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 21 Europe Imaging Devices In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Units)
- Table 22 Europe Tests In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 23 Europe Blood Tests In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 24 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 25 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 26 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Units)
- Table 27 Europe Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 28 Europe Endometrial Cancer In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 29 Europe Endometrial Cancer In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 30 Europe Serous Adenocarcinoma In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 31 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 32 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 33 Europe Adenosquamous Carcinoma In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 34 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 35 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 36 Europe Uterine Carcinosarcoma In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 37 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 38 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 39 Europe Primary Pure Squamous Cell Carcinoma Of The Endometrium In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 40 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 41 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 42 Europe Uterine Sarcoma In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 43 Europe Uterine Sarcoma In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 44 Europe Leiomyosarcoma In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 45 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 46 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 47 Europe Endometrial Stromal Sarcoma In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 48 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 49 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 50 Europe Undifferentiated Sarcoma In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 51 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 52 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 53 Europe Uterine Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 54 Europe >60 Years In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 55 Europe 51-60 Years In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 56 Europe 41-50 Years In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 57 Europe 31-40 Years In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 58 Europe <30 Years In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 59 Europe Uterine Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 60 Europe Hospitals In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 61 Europe Diagnostic Centers In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 62 Europe Cancer Research Centers In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 63 Europe Ambulatory Surgical Centers In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 64 Europe Specialized Clinics In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 65 Europe Others In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 66 Europe Uterine Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 67 Europe Direct Tender In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 68 Europe Third Party Distributors In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 69 Europe Others In Uterine Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 70 Europe Uterine Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
- Table 71 Europe Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 72 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 73 Europe Ultrasound Scanning In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 74 Europe Ultrasound Scanning In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Units)
- Table 75 Europe Ultrasound Scanning In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd)
- Table 76 Europe Systems In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 77 Europe Systems In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Volume)
- Table 78 Europe Systems In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd)
- Table 79 Europe Imaging Devices In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 80 Europe Imaging Devices In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Units)
- Table 81 Europe Imaging Devices In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd)
- Table 82 Europe Tests In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 83 Europe Blood Tests In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 84 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 85 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Volume)
- Table 86 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd)
- Table 87 Europe Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 88 Europe Endometrial Cancer In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 89 Europe Serous Adenocarcinoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 90 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 91 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 92 Europe Adenosquamous Carcinoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 93 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 94 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 95 Europe Uterine Carcinosarcoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 96 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 97 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 98 Europe Primary Pure Squamous Cell Carcinoma Of The Endometrium In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 99 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 100 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 101 Europe Uterine Sarcoma In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 102 Europe Leiomyosarcoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 103 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 104 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 105 Europe Endometrial Stromal Sarcoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 106 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 107 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 108 Europe Undifferentiated Sarcoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 109 Europe Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 110 Europe Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 111 Europe Uterine Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 112 Europe Uterine Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 113 Europe Uterine Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 114 Germany Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 115 Germany Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 116 Germany Ultrasound Scanning In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 117 Germany Ultrasound Scanning In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Units)
- Table 118 Germany Ultrasound Scanning In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd)
- Table 119 Germany Systems In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 120 Germany Systems In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Volume)
- Table 121 Germany Systems In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd)
- Table 122 Germany Imaging Devices In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 123 Germany Imaging Devices In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Units)
- Table 124 Germany Imaging Devices In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd)
- Table 125 Germany Tests In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 126 Germany Blood Tests In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 127 Germany Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 128 Germany Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Volume)
- Table 129 Germany Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd)
- Table 130 Germany Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 131 Germany Endometrial Cancer In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 132 Germany Serous Adenocarcinoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 133 Germany Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 134 Germany Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 135 Germany Adenosquamous Carcinoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 136 Germany Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 137 Germany Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 138 Germany Uterine Carcinosarcoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 139 Germany Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 140 Germany Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 141 Germany Primary Pure Squamous Cell Carcinoma Of The Endometrium In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 142 Germany Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 143 Germany Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 144 Germany Uterine Sarcoma In Uterine Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
- Table 145 Germany Leiomyosarcoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 146 Germany Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 147 Germany Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 148 Germany Endometrial Stromal Sarcoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 149 Germany Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 150 Germany Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 151 Germany Undifferentiated Sarcoma In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 152 Germany Instrument-based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 153 Germany Procedure Based In Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million)
- Table 154 Germany Uterine Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 155 Germany Uterine Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 156 Germany Uterine Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 157 France Uterine Cancer Diagnostics Market, By Diagnostics Type, 2021-2030 (Usd Million) 190
- List Of Figures
- Figure 1 Europe Uterine Cancer Diagnostic Market: Segmentation
- Figure 2 Europe Uterine Cancer Diagnostic Market: Data Triangulation
- Figure 3 Europe Uterine Cancer Diagnostic Market: Droc Analysis
- Figure 4 Europe Uterine Cancer Diagnostic Market: Europe Vs Regional Market Analysis
- Figure 5 Europe Uterine Cancer Diagnostic Market: Company Research Analysis
- Figure 6 Europe Uterine Cancer Diagnostic Market: Interview Demographics
- Figure 7 Europe Uterine Cancer Diagnostic Market: Market Application Coverage Grid
- Figure 8 Europe Uterine Cancer Diagnostic Market: Dbmr Market Position Grid
- Figure 9 Europe Uterine Cancer Diagnostic Market: Vendor Share Analysis
- Figure 10 Europe Uterine Cancer Diagnostic Market: Segmentation
- Figure 11 Growing Awareness Of Uterine Cancer And Increasing Healthcare Expenditure Is Expected To Drive The Growth Of The Europe Uterine Cancer Diagnostic Market From 2023 To 2030
- Figure 12 Instrument Based Segment Is Expected To Account For The Largest Share Of The Europe Uterine Cancer Diagnostic Market In 2023 & 2030
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Uterine Cancer Diagnostics Market
- Figure 14 Europe Uterine Cancer Diagnostics Market : By Diagnostic Type, 2022
- Figure 15 Europe Uterine Cancer Diagnostics Market : By Diagnostic Type, 2023-2030 (Usd Million)
- Figure 16 Europe Uterine Cancer Diagnostics Market : By Diagnostic Type, Cagr (2023-2030)
- Figure 17 Europe Uterine Cancer Diagnostics Market : By Diagnostic Type, Lifeline Curve
- Figure 18 Europe Uterine Cancer Diagnostics Market: By Type, 2022
- Figure 19 Europe Uterine Cancer Diagnostics Market: By Type, 2023-2030 (Usd Million)
- Figure 20 Europe Uterine Cancer Diagnostics Market: By Type, Cagr (2023-2030)
- Figure 21 Europe Uterine Cancer Diagnostics Market: By Type, Lifeline Curve
- Figure 22 Europe Uterine Cancer Diagnostics Market: By Age Group, 2022
- Figure 23 Europe Uterine Cancer Diagnostics Market: By Age Group, 2023-2030 (Usd Million)
- Figure 24 Europe Uterine Cancer Diagnostics Market: By Age Group, Cagr (2023-2030)
- Figure 25 Europe Uterine Cancer Diagnostics Market: By Age Group, Lifeline Curve
- Figure 26 Europe Uterine Cancer Diagnostics Market : By End User, 2022
- Figure 27 Europe Uterine Cancer Diagnostics Market : By End User, 2023-2030 (Usd Million)
- Figure 28 Europe Uterine Cancer Diagnostics Market : By End User, Cagr (2023-2030)
- Figure 29 Europe Uterine Cancer Diagnostics Market : By End User, Lifeline Curve
- Figure 30 Europe Uterine Cancer Diagnostics Market : By Distribution Channel, 2022
- Figure 31 Europe Uterine Cancer Diagnostics Market : By Distribution Channel, 2023-2030 (Usd Million)
- Figure 32 Europe Uterine Cancer Diagnostics Market : By Distribution Channel, Cagr (2023-2030)
- Figure 33 Europe Uterine Cancer Diagnostics Market : By Distribution Channel, Lifeline Curve
- Figure 34 Europe Uterine Cancer Diagnostics Market: Snapshot (2022)
- Figure 35 Europe Uterine Cancer Diagnostics Market: By Country (2022)
- Figure 36 Europe Uterine Cancer Diagnostics Market: By Country (2023 & 2030)
- Figure 37 Europe Uterine Cancer Diagnostics Market: By Country (2022 & 2030)
- Figure 38 Europe Uterine Cancer Diagnostics Market: By Diagnostic Type (2023-2030)
- Figure 39 Europe Uterine Cancer Diagnostics Market: Company Share 2022 (%) 368
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook